These viruses were diluted 10-fold with 0.1% Triton X-100 and assessed by pipetting-based immunoassay for enzymatic colour development
Long-term adjustments may include: Switching from semaglutide to tirzepatide for greater metabolic effect Reducing medication dose once hunger cues stabilize Adding an adjunct oral medication during cravings or increased stress Transitioning to bariatric surgery when medications alone are insufficient Using medication intermittently after reaching the goal weight These decisions are made collaboratively and always prioritize wellness, safety, and long-term stability rather than quick or temporary results
Mann JFE, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, Charytan DM, Hadjadj S, Gillard P, Gorriz JL, Idorn T, Ji L, Mahaffey KW, Perkovic V, Rasmussen S, Schmieder RE, Pratley RE, Tuttle KR
International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)